Guillain–Barré syndrome associated with leptomeningeal enhancement following SARS-CoV-2 infection
Agustín Sancho-Saldaña, Álvaro Lambea-Gil, Jose Luis Capablo Liesa, Maria Rosario Barrena Caballo, Maria Haddad Garay, David Rivero Celada and Marta Serrano-Ponz
DOI: https://doi.org/10.7861/clinmed.2020-0213
Clin Med July 2020 Agustín Sancho-Saldaña
AHospital Universitario Miguel Servet, Zaragoza, Spain
Roles: consultant in neurology
Álvaro Lambea-Gil
AHospital Universitario Miguel Servet, Zaragoza, Spain
Roles: consultant in neurology
Jose Luis Capablo Liesa
AHospital Universitario Miguel Servet, Zaragoza, Spain
Roles: consultant in neurology
Maria Rosario Barrena Caballo
BHospital Universitario Miguel Servet, Zaragoza, Spain
Roles: consultant in neuroradiology
Maria Haddad Garay
CHospital Universitario Miguel Servet, Zaragoza, Spain
Roles: consultant in clinical neurophysiology
David Rivero Celada
DHospital Universitario Miguel Servet, Zaragoza, Spain
Roles: consultant in neurosurgery
Marta Serrano-Ponz
AHospital Universitario Miguel Servet, Zaragoza, Spain
Roles: consultant in neurology
Article Tools
Guillain–Barré syndrome associated with leptomeningeal enhancement following SARS-CoV-2 infection
Agustín Sancho-Saldaña, Álvaro Lambea-Gil, Jose Luis Capablo Liesa, Maria Rosario Barrena Caballo, Maria Haddad Garay, David Rivero Celada, Marta Serrano-Ponz
Clinical Medicine Jul 2020, 20 (4) e93-e94; DOI: 10.7861/clinmed.2020-0213
Citation Manager Formats
Guillain–Barré syndrome associated with leptomeningeal enhancement following SARS-CoV-2 infection
Agustín Sancho-Saldaña, Álvaro Lambea-Gil, Jose Luis Capablo Liesa, Maria Rosario Barrena Caballo, Maria Haddad Garay, David Rivero Celada, Marta Serrano-Ponz
Clinical Medicine Jul 2020, 20 (4) e93-e94; DOI: 10.7861/clinmed.2020-0213
Jump to section
Related Articles
- No related articles found.